| Year |
Citation |
Score |
| 2024 |
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, ... ... Zou W, et al. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity. Nature Communications. 15: 5487. PMID 38942798 DOI: 10.1038/s41467-024-48931-9 |
0.417 |
|
| 2024 |
Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, ... ... Zou W, et al. PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages. Cell Reports. 43: 113942. PMID 38489266 DOI: 10.1016/j.celrep.2024.113942 |
0.384 |
|
| 2024 |
Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, ... ... Zou W, et al. PIKfyve controls dendritic cell function and tumor immunity. Biorxiv : the Preprint Server For Biology. PMID 38464258 DOI: 10.1101/2024.02.28.582543 |
0.367 |
|
| 2024 |
Bell HN, Zou W. Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance. Annual Review of Immunology. PMID 38382538 DOI: 10.1146/annurev-immunol-101819-024752 |
0.305 |
|
| 2024 |
Lo BC, Kryczek I, Yu J, Vatan L, Caruso R, Matsumoto M, Sato Y, Shaw MH, Inohara N, Xie Y, Lei YL, Zou W, Núñez G. Microbiota-dependent activation of CD4 T cells induces CTLA-4 blockade-associated colitis via Fcγ receptors. Science (New York, N.Y.). 383: 62-70. PMID 38175892 DOI: 10.1126/science.adh8342 |
0.351 |
|
| 2023 |
Bao Y, Qiao Y, Choi JE, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove S, Cao X, Su F, Wang R, ... ... Zou W, et al. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 120: e2314416120. PMID 38011559 DOI: 10.1073/pnas.2314416120 |
0.432 |
|
| 2023 |
Zou W, Green DR. Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy. Cell Metabolism. PMID 37390822 DOI: 10.1016/j.cmet.2023.06.003 |
0.378 |
|
| 2023 |
Li G, Choi JE, Kryczek I, Sun Y, Liao P, Li S, Wei S, Grove S, Vatan L, Nelson R, Schaefer G, Allen SG, Sankar K, Fecher LA, Mendiratta-Lala M, ... ... Zou W, et al. Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy. Cancer Cell. PMID 36638784 DOI: 10.1016/j.ccell.2022.12.008 |
0.354 |
|
| 2022 |
Son S, Nam J, Kim AS, Ahn J, Park KS, Phoo MT, Sherren B, Zou W, Lee SH, Farokhzad OC, Shi J, Moon JJ. Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles. Nature Biomedical Engineering. PMID 36564626 DOI: 10.1038/s41551-022-00973-4 |
0.425 |
|
| 2022 |
Hong HS, Mbah NE, Shan M, Loesel K, Lin L, Sajjakulnukit P, Correa LO, Andren A, Lin J, Hayashi A, Magnuson B, Chen J, Li Z, Xie Y, Zhang L, ... ... Zou W, et al. OXPHOS promotes apoptotic resistance and cellular persistence in T17 cells in the periphery and tumor microenvironment. Science Immunology. 7: eabm8182. PMID 36399539 DOI: 10.1126/sciimmunol.abm8182 |
0.366 |
|
| 2022 |
Sun D, Wang W, Guo F, Pitter MR, Du W, Wei S, Grove S, Vatan L, Chen Y, Kryczek I, Fearon ER, Fang JY, Zou W. DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway. Oncoimmunology. 11: 2052640. PMID 35309733 DOI: 10.1080/2162402X.2022.2052640 |
0.367 |
|
| 2022 |
Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gijón M, Shah YM, Zou W. CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. PMID 35216678 DOI: 10.1016/j.ccell.2022.02.003 |
0.405 |
|
| 2022 |
Holcomb EA, Zou W. A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells. The Journal of Clinical Investigation. 132. PMID 35104808 DOI: 10.1172/JCI156628 |
0.304 |
|
| 2021 |
Zou W. Immune regulation in the tumor microenvironment and its relevance in cancer therapy. Cellular & Molecular Immunology. 19: 1-2. PMID 34992273 DOI: 10.1038/s41423-021-00738-0 |
0.333 |
|
| 2021 |
Qiao Y, Choi JE, Tien JC, Simko SA, Rajendiran T, Vo JN, Delekta AD, Wang L, Xiao L, Hodge NB, Desai P, Mendoza S, Juckette K, Xu A, Soni T, ... ... Zou W, et al. Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer. Nature Cancer. 2: 978-993. PMID 34738088 DOI: 10.1038/s43018-021-00237-1 |
0.357 |
|
| 2021 |
Aicher TD, Van Huis CA, Hurd AR, Skalitzky DJ, Taylor CB, Beleh OM, Glick G, Toogood PL, Yang B, Zheng T, Huo C, Gao J, Qiao C, Tian X, Zhang J, ... ... Zou W, et al. Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer. Journal of Medicinal Chemistry. PMID 34499493 DOI: 10.1021/acs.jmedchem.1c00731 |
0.41 |
|
| 2021 |
Chow A, Schad S, Green MD, Hellmann MD, Allaj V, Ceglia N, Zago G, Shah NS, Sharma SK, Mattar M, Chan J, Rizvi H, Zhong H, Liu C, Bykov Y, ... ... Zou W, et al. Tim-4 cavity-resident macrophages impair anti-tumor CD8 T cell immunity. Cancer Cell. PMID 34115989 DOI: 10.1016/j.ccell.2021.05.006 |
0.444 |
|
| 2021 |
Li G, Kryczek I, Nam J, Li X, Li S, Li J, Wei S, Grove S, Vatan L, Zhou J, Du W, Lin H, Wang T, Subramanian C, Moon JJ, ... ... Zou W, et al. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nature Cell Biology. PMID 33958760 DOI: 10.1038/s41556-021-00672-3 |
0.325 |
|
| 2021 |
Thibodeaux S, Barnett B, Pandeswara S, Wall S, Hurez V, Dao V, Sun L, Daniel B, Brumlik MJ, Drerup JM, Padron A, Whiteside TL, Kryczek I, Zou W, Curiel TJ. Interferon-α augments clinical efficacy of regulatory T cell depletion with denileukin diftitox in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33771857 DOI: 10.1158/1078-0432.CCR-20-4594 |
0.383 |
|
| 2021 |
Zhou J, Kryczek I, Li S, Li X, Aguilar A, Wei S, Grove S, Vatan L, Yu J, Yan Y, Liao P, Lin H, Li J, Li G, Du W, ... ... Zou W, et al. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. Nature Immunology. PMID 33767425 DOI: 10.1038/s41590-021-00888-3 |
0.477 |
|
| 2021 |
Okła K, Farber DL, Zou W. Tissue-resident memory T cells in tumor immunity and immunotherapy. The Journal of Experimental Medicine. 218. PMID 33755718 DOI: 10.1084/jem.20201605 |
0.436 |
|
| 2021 |
Lin H, Kryczek I, Li S, Green MD, Ali A, Hamasha R, Wei S, Vatan L, Szeliga W, Grove S, Li X, Li J, Wang W, Yan Y, Choi JE, ... ... Zou W, et al. Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance. Cancer Cell. PMID 33513345 DOI: 10.1016/j.ccell.2020.12.023 |
0.391 |
|
| 2021 |
Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, Chopra Z, El Naqa I, Zhou J, Bian Y, Jiang L, ... ... Zou W, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nature Medicine. PMID 33398162 DOI: 10.1038/s41591-020-1131-x |
0.321 |
|
| 2020 |
Steele NG, Carpenter ES, Kemp SB, Sirihorachai V, The S, Delrosario L, Lazarus J, Amir ED, Gunchick V, Espinoza C, Bell S, Harris L, Lima F, Irizarry-Negron V, Paglia D, ... ... Zou W, et al. Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer. Nature Cancer. 1: 1097-1112. PMID 34296197 DOI: 10.1038/s43018-020-00121-4 |
0.454 |
|
| 2020 |
Zou W. Introduction to the special issue-Barriers and opportunities to cancer immunotherapy in the tumor immune microenvironment. Seminars in Immunology. 49: 101421. PMID 33308923 DOI: 10.1016/j.smim.2020.101421 |
0.349 |
|
| 2020 |
Wang W, Zou W. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. Molecular Cell. PMID 32997964 DOI: 10.1016/j.molcel.2020.09.006 |
0.336 |
|
| 2020 |
Bian Y, Li W, Kremer DM, Sajjakulnukit P, Li S, Crespo J, Nwosu ZC, Zhang L, Czerwonka A, Pawłowska A, Xia H, Li J, Liao P, Yu J, Vatan L, ... ... Zou W, et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature. PMID 32879489 DOI: 10.1038/S41586-020-2682-1 |
0.507 |
|
| 2020 |
Xia H, Li S, Li X, Wang W, Bian Y, Wei S, Grove S, Wang W, Vatan L, Liu JR, McLean K, Rattan R, Munkarah AR, Guan JL, Kryczek I, ... Zou W, et al. Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. Jci Insight. PMID 32780724 DOI: 10.1172/Jci.Insight.141115 |
0.474 |
|
| 2020 |
Li J, Wang W, Zhang Y, Cieślik M, Guo J, Tan M, Green MD, Wang W, Lin H, Li W, Wei S, Zhou J, Li G, Jing X, Vatan L, ... ... Zou W, et al. Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. The Journal of Clinical Investigation. PMID 32027624 DOI: 10.1172/Jci134402 |
0.456 |
|
| 2020 |
Zou W. Abstract IA18: Metabolic impact on cancer immunity Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-Ia18 |
0.606 |
|
| 2020 |
Tan YS, Heath BR, Hill BD, Luo X, Rizvi SM, Moghbeli T, Hu H, Siismets E, Wen H, Xie Y, Sun D, Young S, Zou W, Wen F, Lei YL. Abstract A08: Resolving STING-mediated tumor immune microenvironment shift at single-cell resolution Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A08 |
0.534 |
|
| 2019 |
Lanfranca MP, Zhang Y, Girgis A, Kasselman S, Lazarus J, Kryczek I, Delrosario L, Rhim A, Koneva L, Sartor M, Sun L, Halbrook C, Nathan H, Shi J, Crawford HC, ... ... Zou W, et al. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. Gastroenterology. PMID 31843590 DOI: 10.1053/J.Gastro.2019.12.010 |
0.425 |
|
| 2019 |
Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, ... ... Zou W, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discovery. PMID 31554642 DOI: 10.1158/2159-8290.Cd-19-0338 |
0.46 |
|
| 2019 |
Maj T, Zou W. Rewiring regulatory T cells for tumour killing. Nature Biomedical Engineering. PMID 31384007 DOI: 10.1038/S41551-019-0443-Y |
0.492 |
|
| 2019 |
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, Tian X, Guo F, Liang Q, Liu Q, Zhong M, Chen J, Ge Z, Li X, Chen X, ... ... Zou W, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nature Communications. 10: 3499. PMID 31375671 DOI: 10.1038/S41467-019-11447-8 |
0.331 |
|
| 2019 |
Zou W, Shah YM. A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs. The Journal of Clinical Investigation. 130. PMID 31355780 DOI: 10.1172/Jci130009 |
0.33 |
|
| 2019 |
Lazarus J, Oneka MD, Barua S, Maj T, Lanfranca MP, Delrosario L, Sun L, Smith JJ, D'Angelica MI, Shia J, Fang JM, Shi J, Di Magliano MP, Zou W, Rao A, et al. Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells. Annals of Surgical Oncology. PMID 31250346 DOI: 10.1245/S10434-019-07508-3 |
0.478 |
|
| 2019 |
Zhang Q, Green MD, Lang X, Lazarus J, Parsels J, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei Y, Lawrence TS, ... Zou W, et al. Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy. Cancer Research. PMID 31101760 DOI: 10.1158/0008-5472.Can-19-0761 |
0.419 |
|
| 2019 |
Wang W, Liu JR, Zou W. Immunotherapy in Ovarian Cancer. Surgical Oncology Clinics of North America. 28: 447-464. PMID 31079799 DOI: 10.1016/J.Soc.2019.02.002 |
0.515 |
|
| 2019 |
Liu X, Zawidzka EM, Li H, Lesch CA, Dunbar J, Bousley D, Zou W, Hu X, Carter LL. RORγ agonists enhance the sustained antitumor activity through intrinsic Tc17 cytotoxicity and Tc1 recruitment. Cancer Immunology Research. PMID 31064778 DOI: 10.1158/2326-6066.Cir-18-0714 |
0.516 |
|
| 2019 |
Bishu S, Hou G, El Zaatari M, Bishu SR, Popke D, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PDR, Spence JR, Kamada N, Kao JY. induces tissue-resident memory CD4 T-cells. Infection and Immunity. PMID 31061145 DOI: 10.1128/Iai.00295-19 |
0.493 |
|
| 2019 |
Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, Xia H, Zhou J, Li G, Li J, Li W, ... ... Zou W, et al. CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. PMID 31043744 DOI: 10.1038/S41586-019-1170-Y |
0.513 |
|
| 2019 |
Bishu S, El Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan J, Manoogian B, Muza-Moons MM, Zhang M, Grasberger H, Bourque C, Zou W, Higgins PDR, Spence JR, Stidham RW, et al. CD4+ tissue-resident memory T-cells expand and are a major source of mucosal tumor necrosis factor α in active Crohn's Disease. Journal of Crohn's & Colitis. PMID 30715262 DOI: 10.1093/Ecco-Jcc/Jjz010 |
0.485 |
|
| 2019 |
Green M, Zhang Q, Lang X, Lei Y, Lawrence TS, Zou W, Morgan MA. Abstract B19: Targeting ATM to sensitize pancreatic cancer to immunotherapy and radiotherapy Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B19 |
0.425 |
|
| 2019 |
Qiao Y, Choi JE, Vo JN, Tien JC, Wang L, Xiao L, Simko SA, Delekta AD, Hodge NB, Desai P, Juckette K, Xu A, Su F, Wang R, Cao X, ... ... Zou W, et al. Abstract 4153: Therapeutic targeting autophagy to sensitize cancer immunotherapy in various cancer types Cancer Research. 79: 4153-4153. DOI: 10.1158/1538-7445.Am2019-4153 |
0.438 |
|
| 2019 |
Nam J, Son S, Park KS, Zou W, Shea LD, Moon JJ. Cancer nanomedicine for combination cancer immunotherapy Nature Reviews Materials. 4: 398-414. DOI: 10.1038/S41578-019-0108-1 |
0.353 |
|
| 2019 |
Bishu S, Hou G, El-Zaatari M, Bishu S, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PD, Spence J, Kamada N, Kao JY. Mo1927 – Citrobacter Rodentium Induces Cd4+ Tissue Resident Memory T-Cells that Expand with Re-Challenge Gastroenterology. 156: S-889-S-890. DOI: 10.1016/S0016-5085(19)39194-2 |
0.374 |
|
| 2019 |
Bishu S, El-Zaatari M, Hayashi A, Hou G, Bowers N, Kinnucan JA, Manoogian B, Muza-Moons M, Zhang M, Grasberger H, Zou W, Higgins PD, Spence J, Stidham RW, Kamada N, et al. Mo1877 – Tumor Necrosis Factor α and Il-17A Producing Cd4+ Tissue Resident Memory T-Cells are Expanded in Crohn’s and are Inhibited by the Anti-Inflammtory Microbial Metabolite Butyrate Gastroenterology. 156: S-872. DOI: 10.1016/S0016-5085(19)39144-9 |
0.436 |
|
| 2018 |
Lanfranca MP, Lazarus J, Shao X, Nathan H, Di Magliano MP, Zou W, Piert M, Frankel TL. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28. The Journal of Surgical Research. 232: 570-577. PMID 30463776 DOI: 10.1016/J.Jss.2018.07.015 |
0.37 |
|
| 2018 |
Lazarus J, Maj T, Smith JJ, Perusina Lanfranca M, Rao A, D'Angelica MI, Delrosario L, Girgis A, Schukow C, Shia J, Kryczek I, Shi J, Wasserman I, Crawford H, Nathan H, ... ... Zou W, et al. Spatial and phenotypic immune profiling of metastatic colon cancer. Jci Insight. 3. PMID 30429368 DOI: 10.1172/Jci.Insight.121932 |
0.453 |
|
| 2018 |
Wang W, Zou W, Liu JR. Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy. Gynecologic Oncology. 151: 1-3. PMID 30243508 DOI: 10.1016/J.Ygyno.2018.09.005 |
0.533 |
|
| 2018 |
Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, ... Zou W, et al. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. Cell. 173: 1770-1782.e14. PMID 29906450 DOI: 10.1016/J.Cell.2018.04.034 |
0.367 |
|
| 2018 |
Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, ... ... Zou W, et al. Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism. PMID 29805099 DOI: 10.1016/J.Cmet.2018.04.022 |
0.509 |
|
| 2018 |
Crespo J, Wu K, Li W, Kryczek I, Maj T, Vatan L, Wei S, Opipari AW, Zou W. Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. Journal of Immunology (Baltimore, Md. : 1950). PMID 29802127 DOI: 10.4049/Jimmunol.1700755 |
0.562 |
|
| 2018 |
Hu X, Majchrzak K, Liu X, Wyatt MM, Spooner C, Moisan J, Zou W, Carter LL, Paulos CM. In vitro priming of adoptively transferred T cells with a RORγ agonist confers durable memory and stemness in vivo. Cancer Research. PMID 29769201 DOI: 10.1158/0008-5472.Can-17-3973 |
0.57 |
|
| 2018 |
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine. PMID 29686425 DOI: 10.1038/S41591-018-0014-X |
0.409 |
|
| 2018 |
Zou W. Mechanistic insights into cancer immunity and immunotherapy. Cellular & Molecular Immunology. PMID 29572549 DOI: 10.1038/S41423-018-0011-5 |
0.39 |
|
| 2018 |
Yentz SE, Reimers MA, Joshi M, Zakharia Y, Gupta S, Singer EA, Daignault S, Zou W, Musapatika D, Alva AS. Single-arm phase ib/II study of durvalumab and guadecitabine in advanced kidney cancer (NCT03308396). Journal of Clinical Oncology. 36: TPS711-TPS711. DOI: 10.1200/Jco.2018.36.6_Suppl.Tps711 |
0.445 |
|
| 2018 |
Zou W. Abstract SY17-01: Metabolic impact on immune cell subsets in the tumor microenvironment and its therapeutic relevance Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Sy17-01 |
0.589 |
|
| 2017 |
Frankel T, Lanfranca MP, Zou W. The Role of Tumor Microenvironment in Cancer Immunotherapy. Advances in Experimental Medicine and Biology. 1036: 51-64. PMID 29275464 DOI: 10.1007/978-3-319-67577-0_4 |
0.482 |
|
| 2017 |
Crespo J, Vatan L, Maj T, Liu R, Kryczek I, Zou W. Phenotype and tissue distribution of CD28H+ immune cell subsets. Oncoimmunology. 6: e1362529. PMID 29209568 DOI: 10.1080/2162402X.2017.1362529 |
0.524 |
|
| 2017 |
Xia H, Wang W, Crespo J, Kryczek I, Li W, Wei S, Bian Z, Maj T, He M, Liu RJ, He Y, Rattan R, Munkarah A, Guan JL, Zou W. Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity. Science Immunology. 2. PMID 29150439 DOI: 10.1126/Sciimmunol.Aan4631 |
0.539 |
|
| 2017 |
Maj T, Wang W, Crespo J, Zhang H, Wang W, Wei S, Zhao L, Vatan L, Shao I, Szeliga W, Lyssiotis C, Liu JR, Kryczek I, Zou W. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nature Immunology. PMID 29083399 DOI: 10.1038/Ni.3868 |
0.553 |
|
| 2017 |
Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 170: 548-563.e16. PMID 28753429 DOI: 10.1016/J.Cell.2017.07.008 |
0.327 |
|
| 2017 |
Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews. Immunology. PMID 28555670 DOI: 10.1038/Nri.2017.49 |
0.458 |
|
| 2017 |
Fang M, Li Y, Huang K, Qi S, Zhang J, Zgodzinski W, Majewski M, Wallner G, Gozdz S, Macek P, Kowalik A, Pasiarski M, Grywalska E, Vatan L, Nagarsheth N, ... ... Zou W, et al. IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment. Cancer Research. PMID 28249897 DOI: 10.1158/0008-5472.Can-16-1602 |
0.497 |
|
| 2017 |
Li J, Xi Y, Li W, McCarthy RL, Stratton SA, Zou W, Li W, Dent SY, Jain AK, Barton MC. TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. Oncogene. PMID 28068325 DOI: 10.1038/Onc.2016.453 |
0.338 |
|
| 2017 |
Zou W. Cancer epigenetics and effector T cells in immunotherapy and chemotherapy. Journal of Clinical Oncology. 35: 17-17. DOI: 10.1200/jco.2017.35.7_suppl.17 |
0.473 |
|
| 2017 |
Cui B, Cao X, Zou W, Wan Y, Wang N, Wang Y, Li P, Hua F, Liu Y, Zhang X, Li K, Lv X, Huang B, Hu Z. Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology Acta Pharmaceutica Sinica B. 7: 532-540. DOI: 10.1016/J.Apsb.2017.06.007 |
0.311 |
|
| 2016 |
Hu X, Liu X, Moisan J, Wang Y, Lesch CA, Spooner C, Morgan RW, Zawidzka EM, Mertz D, Bousley D, Majchrzak K, Kryczek I, Taylor C, Van Huis C, Skalitzky D, ... ... Zou W, et al. Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology. 5: e1254854. PMID 28123897 DOI: 10.1080/2162402X.2016.1254854 |
0.547 |
|
| 2016 |
Kryczek I, Wang L, Wu K, Li W, Zhao E, Cui T, Wei S, Liu Y, Wang Y, Vatan L, Szeliga W, Greenson JK, Roliński J, Zgodzinski W, Huang E, ... ... Zou W, et al. Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma. Oncoimmunology. 5: e1105430. PMID 27622054 DOI: 10.1080/2162402X.2015.1105430 |
0.515 |
|
| 2016 |
Sun D, Lin Y, Hong J, Chen H, Nagarsheth N, Peng D, Wei S, Huang E, Fang J, Kryczek I, Zou W. Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling. Oncoimmunology. 5: e1082704. PMID 27622053 DOI: 10.1080/2162402X.2015.1082704 |
0.47 |
|
| 2016 |
Peng D, Tanikawa T, Li W, Zhao L, Vatan L, Szeliga W, Wan S, Wei S, Wang Y, Liu Y, Staroslawska E, Szubstarski F, Rolinski J, Grywalska E, Stanislawek A, ... ... Zou W, et al. Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL-6/STAT3 and NO/NOTCH cross-talk signaling. Cancer Research. PMID 27197152 DOI: 10.1158/0008-5472.Can-15-2528 |
0.471 |
|
| 2016 |
Sun TT, He J, Liang Q, Ren LL, Yan TT, Yu TC, Tang JY, Bao YJ, Hu Y, Lin Y, Sun D, Chen YX, Hong J, Chen H, Zou W, et al. A novel lncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discovery. PMID 27147598 DOI: 10.1158/2159-8290.Cd-15-0921 |
0.321 |
|
| 2016 |
Wang W, Kryczek I, Dostál L, Lin H, Tan L, Zhao L, Lu F, Wei S, Maj T, Peng D, He G, Vatan L, Szeliga W, Kuick R, Kotarski J, ... ... Zou W, et al. Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. Cell. PMID 27133165 DOI: 10.1016/J.Cell.2016.04.009 |
0.525 |
|
| 2016 |
Li Y, Fang M, Zhang J, Wang J, Song Y, Shi J, Li W, Wu G, Ren J, Wang Z, Zou W, Wang L. Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology. 5: e1074374. PMID 27057439 DOI: 10.1080/2162402X.2015.1074374 |
0.49 |
|
| 2016 |
Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science Translational Medicine. 8: 328rv4. PMID 26936508 DOI: 10.1126/Scitranslmed.Aad7118 |
0.329 |
|
| 2016 |
Perusina Lanfranca M, Lin Y, Fang J, Zou W, Frankel T. Biological and pathological activities of interleukin-22. Journal of Molecular Medicine (Berlin, Germany). PMID 26923718 DOI: 10.1007/S00109-016-1391-6 |
0.416 |
|
| 2016 |
Zou W. Abstract IA28: Cancer epigenetic and metabolic mechanisms controlling immunotherapy and chemotherapy Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-Ia28 |
0.582 |
|
| 2015 |
Nagarsheth N, Peng D, Kryczek I, Wu K, Li W, Zhao E, Zhao L, Wei S, Frankel T, Vatan L, Szeliga W, Dou Y, Owens S, Marquez V, Tao K, ... ... Zou W, et al. PRC2 epigenetically silences Th1-type chemokines to suppress effector T cell trafficking in colon cancer. Cancer Research. PMID 26567139 DOI: 10.1158/0008-5472.Can-15-1938 |
0.581 |
|
| 2015 |
Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, Wei S, Crespo J, Wan S, Vatan L, Szeliga W, Shao I, Wang Y, Liu Y, Varambally S, ... ... Zou W, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nature Immunology. PMID 26523864 DOI: 10.1038/Ni.3313 |
0.527 |
|
| 2015 |
Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, Sun Y, Zhao E, Vatan L, Szeliga W, Kotarski J, Tarkowski R, Dou Y, Cho K, Hensley-Alford S, ... ... Zou W, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. PMID 26503055 DOI: 10.1038/Nature15520 |
0.474 |
|
| 2015 |
Maj T, Zou W. Dendritic cells are stressed out in tumor. Cell Research. 25: 989-90. PMID 26227962 DOI: 10.1038/Cr.2015.93 |
0.423 |
|
| 2015 |
Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, ... ... Zou W, et al. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 4: e998538. PMID 26137416 DOI: 10.1080/2162402X.2014.998538 |
0.511 |
|
| 2015 |
Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, Del Valle L, Trillo-Tinoco J, Maj T, Zou W, Rodriguez PC, Ochoa AC. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Cancer Immunology Research. PMID 26025381 DOI: 10.1186/2051-1426-3-S2-O18 |
0.505 |
|
| 2015 |
Wan S, Kuo N, Kryczek I, Zou W, Welling TH. Myeloid cells in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 25914264 DOI: 10.1002/Hep.27867 |
0.368 |
|
| 2015 |
Hu X, Moisan J, Majchrzak K, Lesch C, Wang Y, Sanchez B, Liu X, Morgan R, Mertz D, Bousley D, van Huis C, Skalitzky D, Taylor C, Aicher T, Toogood P, ... Zou W, et al. RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P23 |
0.528 |
|
| 2015 |
Kryczek I, Cui TX, Zhao L, Vatan L, Szeliga W, Liu R, Zou W. Abstract POSTER-BIOL-1332: Molecular, cellular and clinical interaction between MDSC and ovarian cancer stemness Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1332 |
0.437 |
|
| 2015 |
Hu X, Moisan J, Lesch C, Wang Y, Liu X, Morgan R, Mertz D, Sanchez B, Bousley D, Taylor C, Huis CV, Aicher T, Toogood P, Zou W, Glick G, et al. Abstract 4273: RORγ agonists as a novel immunotherapy approach for cancer Cancer Research. 75: 4273-4273. DOI: 10.1158/1538-7445.Am2015-4273 |
0.577 |
|
| 2015 |
Alawad A, Altuwaijri S, Aljarbu A, Kryczek I, Niu Y, Al-Sobayil FA, Chang C, Bayoumi A, Zou W, Rudat V, Hammad M. Depletion of androgen receptor (AR) in mesenchymal stem cells (MSCs) inhibits induction of CD4+CD25+FOX3+ regulatory T (Treg) cells via androgen TGF-β interaction Journal of Applied Biomedicine. 13: 263-271. DOI: 10.1016/J.Jab.2015.06.002 |
0.423 |
|
| 2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Zou W, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998 |
0.411 |
|
| 2014 |
Hu Y, Wang J, Qian J, Kong X, Tang J, Wang Y, Chen H, Hong J, Zou W, Chen Y, Xu J, Fang JY. Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Research. 74: 6890-902. PMID 25277524 DOI: 10.1158/0008-5472.Can-14-0686 |
0.353 |
|
| 2014 |
Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. 147: 1393-404. PMID 25181692 DOI: 10.1053/J.Gastro.2014.08.039 |
0.331 |
|
| 2014 |
Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, Vatan L, Szeliga W, Dou Y, Owens S, Zgodzinski W, Majewski M, Wallner G, Fang J, Huang E, ... Zou W, et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity. 40: 772-84. PMID 24816405 DOI: 10.1016/J.Immuni.2014.03.010 |
0.468 |
|
| 2014 |
Hu X, Liu X, Morgan R, Moisan J, Hao L, Wang Y, Sanchez B, Lesch C, Bousley D, Taylor C, Aicher T, Toogood P, Zou W, Glick G, Carter L. Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach Journal For Immunotherapy of Cancer. 2: P194. DOI: 10.1186/2051-1426-2-S3-P194 |
0.534 |
|
| 2014 |
Thibodeaux S, Hurez V, Wall S, Pandeswara S, Daniel B, Liu A, Sun L, Wood L, Zou W, Curiel T. Abstract LB-259: Interferon-α enhances clinical benefits of regulatory T cell depletion in ovarian cancer through direct T cell effects and by inducing bystander IL-6 Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-259 |
0.542 |
|
| 2014 |
Zhao E, Maj T, Kryczek I, Zhao L, Wei S, Wan S, Crespo J, Szeliga W, Vatan L, Wu K, Chinnaiyan AM, Welling TH, Marquez VE, Kotarski J, Zhang Y, ... ... Zou W, et al. Abstract 4078: EZH2 marks polyfunctional memory T cells and controls tumor immunity Cancer Research. 74: 4078-4078. DOI: 10.1158/1538-7445.Am2014-4078 |
0.556 |
|
| 2013 |
Maj T, Wei S, Welling T, Zou W. T cells and costimulation in cancer. Cancer Journal (Sudbury, Mass.). 19: 473-82. PMID 24270346 DOI: 10.1097/Ppo.0000000000000002 |
0.546 |
|
| 2013 |
Kong X, Qian J, Chen LS, Wang YC, Wang JL, Chen H, Weng YR, Zhao SL, Hong J, Chen YX, Zou W, Xu J, Fang JY. Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. Journal of the National Cancer Institute. 105: 1738-49. PMID 24104608 DOI: 10.1093/Jnci/Djt271 |
0.348 |
|
| 2013 |
Sun X, Zhang M, El-Zataari M, Owyang SY, Eaton KA, Liu M, Chang YM, Zou W, Kao JY. TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. Plos One. 8: e74595. PMID 24058595 DOI: 10.1371/Journal.Pone.0074595 |
0.334 |
|
| 2013 |
Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG, Kotarski J, Tarkowski R, Wicha M, Cho K, Giordano T, ... ... Zou W, et al. Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity. 39: 611-21. PMID 24012420 DOI: 10.1016/J.Immuni.2013.08.025 |
0.452 |
|
| 2013 |
Lin YW, Ren LL, Xiong H, Du W, Yu YN, Sun TT, Weng YR, Wang ZH, Wang JL, Wang YC, Cui Y, Sun DF, Han ZG, Shen N, Zou W, et al. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. The Journal of Pathology. 230: 277-90. PMID 23424038 DOI: 10.1002/Path.4179 |
0.345 |
|
| 2013 |
Wei S, Egenti MU, Teitz-Tennenbaum S, Zou W, Chang AE. Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 124-32. PMID 23377667 DOI: 10.1097/Cji.0B013E31828298E6 |
0.544 |
|
| 2013 |
Crespo J, Sun H, Welling TH, Tian Z, Zou W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Current Opinion in Immunology. 25: 214-21. PMID 23298609 DOI: 10.1016/J.Coi.2012.12.003 |
0.551 |
|
| 2013 |
Kryczek I, Zou W. Abstract IA4: T cell subsets in the tumor microenvironment. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-Ia4 |
0.511 |
|
| 2013 |
Wang W, Zou W. Therapeutic targeting regulatory T cells in tumor The Tumor Immunoenvironment. 2147483647: 585-602. DOI: 10.1007/978-94-007-6217-6_25 |
0.458 |
|
| 2012 |
Welling TH, Fu S, Wan S, Zou W, Marrero JA. Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Investigation. 30: 689-97. PMID 23072563 DOI: 10.3109/07357907.2012.732161 |
0.329 |
|
| 2012 |
Zou W, Restifo NP. Nine lives for TH9s? Nature Medicine. 18: 1177-8. PMID 22869182 DOI: 10.1038/Nm.2868 |
0.555 |
|
| 2012 |
Wei S, Zhao E, Kryczek I, Zou W. Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology. 1: 516-519. PMID 22754771 DOI: 10.4161/Onci.19440 |
0.549 |
|
| 2012 |
Zhao E, Wang L, Dai J, Kryczek I, Wei S, Vatan L, Altuwaijri S, Sparwasser T, Wang G, Keller ET, Zou W. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology. 1: 152-161. PMID 22720236 DOI: 10.4161/Onci.1.2.18480 |
0.381 |
|
| 2012 |
Li H, Wu K, Tao K, Chen L, Zheng Q, Lu X, Liu J, Shi L, Liu C, Wang G, Zou W. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology (Baltimore, Md.). 56: 1342-51. PMID 22505239 DOI: 10.1002/Hep.25777 |
0.487 |
|
| 2012 |
Peng DJ, Liu R, Zou W. Regulatory T cells in human ovarian cancer. Journal of Oncology. 2012: 345164. PMID 22481922 DOI: 10.1155/2012/345164 |
0.563 |
|
| 2012 |
Wilcox RA, Ansell SM, Lim MS, Zou W, Chen L. The B7 homologues and their receptors in hematologic malignancies. European Journal of Haematology. 88: 465-75. PMID 22372959 DOI: 10.1111/J.1600-0609.2012.01766.X |
0.348 |
|
| 2012 |
Ménétrier-Caux C, Curiel T, Faget J, Manuel M, Caux C, Zou W. Targeting regulatory T cells. Targeted Oncology. 7: 15-28. PMID 22327882 DOI: 10.1007/S11523-012-0208-Y |
0.543 |
|
| 2012 |
Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Núñez G, Zou W. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Research. 72: 420-9. PMID 22123924 DOI: 10.1158/0008-5472.Can-10-4627 |
0.794 |
|
| 2012 |
Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, Wang G, Zou W. Bone marrow and the control of immunity. Cellular & Molecular Immunology. 9: 11-9. PMID 22020068 DOI: 10.1038/Cmi.2011.47 |
0.44 |
|
| 2012 |
Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. International Journal of Cancer. 130: 29-39. PMID 21480217 DOI: 10.1002/Ijc.25967 |
0.419 |
|
| 2012 |
Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, Klimczak A, Lange A, Zou W. Abstract 3534: Human Th17 cells have stem cell-like features and promote long-term tumor immunity Cancer Research. 72: 3534-3534. DOI: 10.1158/1538-7445.Am2012-3534 |
0.561 |
|
| 2012 |
Wan S, Vatan L, Simeone DM, Kryczek IE, Zou W, Welling TH. Abstract 315: Immune cells promote hepatocellular carcinoma stemness phenotype Cancer Research. 72: 315-315. DOI: 10.1158/1538-7445.Am2012-315 |
0.437 |
|
| 2012 |
Wilke CM, Wei S, Wang L, Kryczek I, Fang J, Wang G, Zou W. T cell and antigen-presenting cell subsets in the tumor microenvironment Cancer Immunotherapy: Paradigms, Practice and Promise. 17-44. DOI: 10.1007/978-1-4614-4732-0_2 |
0.8 |
|
| 2011 |
Wilke CM, Wang L, Wei S, Kryczek I, Huang E, Kao J, Lin Y, Fang J, Zou W. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. Journal of Translational Medicine. 9: 217. PMID 22176654 DOI: 10.1186/1479-5876-9-217 |
0.771 |
|
| 2011 |
Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, Klimczak A, Lange A, Zou W. Human TH17 cells are long-lived effector memory cells. Science Translational Medicine. 3: 104ra100. PMID 21998407 DOI: 10.1126/Scitranslmed.3002949 |
0.518 |
|
| 2011 |
Wilke CM, Bishop K, Fox D, Zou W. Deciphering the role of Th17 cells in human disease. Trends in Immunology. 32: 603-11. PMID 21958759 DOI: 10.1016/J.It.2011.08.003 |
0.79 |
|
| 2011 |
Wilke CM, Wei S, Wang L, Kryczek I, Kao J, Zou W. Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer Immunology, Immunotherapy : Cii. 60: 1529-41. PMID 21918895 DOI: 10.1007/S00262-011-1104-5 |
0.793 |
|
| 2011 |
Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes & Development. 25: 1510-27. PMID 21764854 DOI: 10.1101/Gad.2051011 |
0.47 |
|
| 2011 |
Wilke CM, Kryczek I, Zou W. Antigen-presenting cell (APC) subsets in ovarian cancer. International Reviews of Immunology. 30: 120-6. PMID 21557638 DOI: 10.3109/08830185.2011.567362 |
0.799 |
|
| 2011 |
Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, Greenson J, Chang A, Roliński J, Radwan P, Fang J, Wang G, Zou W. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. Journal of Immunology (Baltimore, Md. : 1950). 186: 4388-95. PMID 21357259 DOI: 10.4049/Jimmunol.1003251 |
0.563 |
|
| 2011 |
Wilke CM, Zou W. T lymphocytes to IDO+ cells: check. Blood. 117: 2082-3. PMID 21330479 DOI: 10.1182/Blood-2010-12-322172 |
0.787 |
|
| 2011 |
Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G, Zou W. Th17 cells in cancer: help or hindrance? Carcinogenesis. 32: 643-9. PMID 21304053 DOI: 10.1093/Carcin/Bgr019 |
0.816 |
|
| 2011 |
Wan S, Vatan L, Simeone DM, Kryczek I, Zou W, Welling TH. Abstract 2450: Resistance of CD44+ hepatocellular carcinoma cancer stem cellsto immune effector responses Cancer Research. 71: 2450-2450. DOI: 10.1158/1538-7445.Am2011-2450 |
0.441 |
|
| 2011 |
Zou W, Restifo NP. Erratum: TH 17 cells in tumour immunity and immunotherapy (Nature Reviews Immunology (2010) 10 (248-256)) Nature Reviews Immunology. 11: 565-565. DOI: 10.1038/Nri3029 |
0.439 |
|
| 2010 |
Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, Toubai T, Duran-Struuck R, Sun Y, Clouthier SG, Evers R, Lowler KP, Levy RB, Reddy P. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 3866-72. PMID 20810991 DOI: 10.4049/Jimmunol.1001625 |
0.428 |
|
| 2010 |
Wilke CM, Wu K, Zhao E, Wang G, Zou W. Prognostic significance of regulatory T cells in tumor. International Journal of Cancer. Journal International Du Cancer. 127: 748-58. PMID 20473951 DOI: 10.1002/Ijc.25464 |
0.811 |
|
| 2010 |
Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nature Reviews. Immunology. 10: 248-56. PMID 20336152 DOI: 10.1038/Nri2742 |
0.503 |
|
| 2010 |
Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 138: 1046-54. PMID 19931266 DOI: 10.1053/J.Gastro.2009.11.043 |
0.462 |
|
| 2010 |
Wei S, Kryczek I, Namm J, Szeliga W, Vatan L, Chang AE, Zou W. Response: Endogenous IL-17, tumor growth, and metastasis Blood. 115: 2556-2557. DOI: 10.1182/Blood-2010-01-255737 |
0.442 |
|
| 2009 |
Faust SM, Lu G, Marini BL, Zou W, Gordon D, Iwakura Y, Laouar Y, Bishop DK. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. Journal of Immunology (Baltimore, Md. : 1950). 183: 7297-306. PMID 19917689 DOI: 10.4049/Jimmunol.0902446 |
0.438 |
|
| 2009 |
Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Research. 69: 8067-75. PMID 19826049 DOI: 10.1158/0008-5472.Can-09-0901 |
0.404 |
|
| 2009 |
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood. 114: 1141-9. PMID 19470694 DOI: 10.1182/Blood-2009-03-208249 |
0.609 |
|
| 2009 |
Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, Redman B, Welling TH, Chang A, Zou W. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Research. 69: 3995-4000. PMID 19383912 DOI: 10.1158/0008-5472.Can-08-3804 |
0.557 |
|
| 2009 |
Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood. 114: 357-9. PMID 19289853 DOI: 10.1182/Blood-2008-09-177360 |
0.525 |
|
| 2009 |
Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Frontiers in Bioscience (Landmark Edition). 14: 1761-70. PMID 19273160 DOI: 10.2741/3338 |
0.549 |
|
| 2009 |
Welling TH, Wu K, Kryczek I, Zou W. QS157. Antigen Presenting Cell B7-H1 and T Cell PD-1 are Increased in Human Hepatocellular Carcinoma: Evidence for Increased Immune Regulation Journal of Surgical Research. 151: 289. DOI: 10.1016/J.Jss.2008.11.455 |
0.434 |
|
| 2008 |
Kryczek I, Wei S, Gong W, Shu X, Szeliga W, Vatan L, Chen L, Wang G, Zou W. Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. Journal of Immunology (Baltimore, Md. : 1950). 181: 5842-6. PMID 18941172 DOI: 10.4049/Jimmunol.181.9.5842 |
0.431 |
|
| 2008 |
Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, Szeliga W, Wang Y, Liu Y, Welling TH, Elder JT, Zou W. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. Journal of Immunology (Baltimore, Md. : 1950). 181: 4733-41. PMID 18802076 DOI: 10.4049/Jimmunol.181.7.4733 |
0.494 |
|
| 2008 |
Wei S, Shreiner AB, Takeshita N, Chen L, Zou W, Chang AE. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Research. 68: 5432-8. PMID 18593946 DOI: 10.1158/0008-5472.Can-07-6598 |
0.476 |
|
| 2008 |
Wei S, Curiel T, Coukos G, Liu R, Zou W. Inhibitory B7 family members in human ovarian carcinoma. Advances in Experimental Medicine and Biology. 622: 261-71. PMID 18546634 DOI: 10.1007/978-0-387-68969-2_21 |
0.515 |
|
| 2008 |
Barnett BG, Rüter J, Kryczek I, Brumlik MJ, Cheng PJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Regulatory T cells: a new frontier in cancer immunotherapy. Advances in Experimental Medicine and Biology. 622: 255-60. PMID 18546633 DOI: 10.1007/978-0-387-68969-2_20 |
0.479 |
|
| 2008 |
Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nature Reviews. Immunology. 8: 467-77. PMID 18500231 DOI: 10.1038/Nri2326 |
0.404 |
|
| 2007 |
Reddy P, Zou W. Blocking HDACs boosts regulatory T cells. Nature Medicine. 13: 1282-4. PMID 17987020 DOI: 10.1038/Nm1107-1282 |
0.397 |
|
| 2007 |
Wei S, Daniel BJ, Brumlik MJ, Burow ME, Zou W, Khan IA, Wadsworth S, Siekierka J, Curiel TJ. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrobial Agents and Chemotherapy. 51: 4324-8. PMID 17923491 DOI: 10.1128/Aac.00680-07 |
0.318 |
|
| 2007 |
Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Research. 67: 8900-5. PMID 17875732 DOI: 10.1158/0008-5472.Can-07-1866 |
0.521 |
|
| 2007 |
Wei S, Kryczek I, Edwards RP, Zou L, Szeliga W, Banerjee M, Cost M, Cheng P, Chang A, Redman B, Herberman RB, Zou W. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Research. 67: 7487-94. PMID 17671219 DOI: 10.1158/0008-5472.Can-07-0565 |
0.554 |
|
| 2007 |
Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. Journal of Immunology (Baltimore, Md. : 1950). 179: 1423-6. PMID 17641006 DOI: 10.4049/Jimmunol.179.3.1423 |
0.405 |
|
| 2007 |
Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment Journal of Immunology. 178: 6730-6733. PMID 17513719 DOI: 10.4049/Jimmunol.178.11.6730 |
0.583 |
|
| 2007 |
Hamdi H, Godot V, Maillot MC, Prejean MV, Cohen N, Krzysiek R, Lemoine FM, Zou W, Emilie D. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood. 110: 211-9. PMID 17356131 DOI: 10.1182/Blood-2006-10-052506 |
0.439 |
|
| 2007 |
Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. American Journal of Physiology. Cell Physiology. 292: C987-95. PMID 16943240 DOI: 10.1152/Ajpcell.00406.2006 |
0.417 |
|
| 2007 |
Kryczek I, Zou W. Response to Comment on “Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells” The Journal of Immunology. 178: 4706-4706. DOI: 10.4049/Jimmunol.178.8.4706 |
0.384 |
|
| 2007 |
Rüter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. T-Regulatory Cell Manipulation in Tumor Immunotherapy Cancer Vaccines and Tumor Immunity. 189-204. DOI: 10.1002/9780470170113.ch12 |
0.437 |
|
| 2006 |
Barnett BG, Ruter J, Brumlik MJ, Kryczek I, Cheng PJ, Zou W, Curiel TJ. A phase II trial of denileukin diftitox to treat refractory advanced-stage ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2506. PMID 27954747 DOI: 10.1200/Jco.2006.24.18_Suppl.2506 |
0.427 |
|
| 2006 |
Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 40-4. PMID 16785496 DOI: 10.4049/Jimmunol.177.1.40 |
0.508 |
|
| 2006 |
Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. The Journal of Experimental Medicine. 203: 871-81. PMID 16606666 DOI: 10.1084/Jem.20050930 |
0.462 |
|
| 2006 |
Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews. Immunology. 6: 295-307. PMID 16557261 DOI: 10.1038/Nri1806 |
0.486 |
|
| 2006 |
Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood. 108: 426-31. PMID 16537800 DOI: 10.1182/Blood-2006-01-0177 |
0.524 |
|
| 2006 |
Rüter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Manipulating T regulatory cells in cancer immunotherapy Expert Review of Dermatology. 1: 589-597. DOI: 10.1586/17469872.1.4.589 |
0.505 |
|
| 2006 |
curiel T, Barnett B, Zou W, Kryczek I, Brumlik M, Cheng J, Rueter J. 23 INVITED T regs in cancer European Journal of Cancer Supplements. 4: 11. DOI: 10.1016/S1359-6349(06)70028-3 |
0.395 |
|
| 2005 |
Wei S, Kryczek I, Zou L, Curiel T, Cheng P, Zou W. Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells. Discovery Medicine. 5: 489-92. PMID 20704848 |
0.458 |
|
| 2005 |
Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. Regulatory T cells in ovarian cancer: biology and therapeutic potential. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 54: 369-77. PMID 16305662 DOI: 10.1111/J.1600-0897.2005.00330.X |
0.563 |
|
| 2005 |
Kryczek I, Frydman N, Gaudin F, Krzysiek R, Fanchin R, Emilie D, Chouaib S, Zou W, Machelon V. The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 54: 270-83. PMID 16212649 DOI: 10.1111/J.1600-0897.2005.00307.X |
0.435 |
|
| 2005 |
Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Research. 65: 5020-6. PMID 15958543 DOI: 10.1158/0008-5472.Can-04-4043 |
0.569 |
|
| 2005 |
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews. Cancer. 5: 263-74. PMID 15776005 DOI: 10.1038/Nrc1586 |
0.337 |
|
| 2005 |
Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. 290 DEPLETING REGULATORY T CELLS IS ASSOCIATED WITH IMPROVED IMMUNITY AND TUMOR CLEARANCE IN HUMAN CANCER Journal of Investigative Medicine. 53: S304.4-S304. DOI: 10.2310/6650.2005.00006.218 |
0.53 |
|
| 2005 |
Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. 219 DEPLETING REGULATORY T CELLS IS ASSOCIATED WITH IMPROVED IMMUNITY AND TUMOR CLEARANCE IN HUMAN CANCER Journal of Investigative Medicine. 53: S291.3-S291. DOI: 10.2310/6650.2005.00006.218 |
0.474 |
|
| 2004 |
Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Research. 64: 8451-5. PMID 15548717 DOI: 10.1158/0008-5472.Can-04-1987 |
0.377 |
|
| 2004 |
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, ... ... Zou W, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine. 10: 942-9. PMID 15322536 DOI: 10.1038/Nm1093 |
0.585 |
|
| 2004 |
Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Research. 64: 5535-8. PMID 15313886 DOI: 10.1158/0008-5472.Can-04-1272 |
0.459 |
|
| 2003 |
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, ... ... Zou W, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Medicine. 9: 562-7. PMID 12704383 DOI: 10.1038/Nm863 |
0.499 |
|
| 2003 |
CURIEL T, LANDRY S, MORRIS C, JOSHI V, BERGGREN R, HAWKINS C, ZOU W, LACKNER A, MOHAMADZADEH M. 293 Targeting HCV NS3 to dendritic cells (DC) via DC-binding peptides induces potent T cell immunity I in vivo Hepatology. 38: 297-297. DOI: 10.1016/S0270-9139(03)80336-1 |
0.384 |
|
| 2002 |
Wei S, Marches F, Borvak J, Zou W, Channon J, White M, Radke J, Cesbron-Delauw MF, Curiel TJ. Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infection and Immunity. 70: 1750-60. PMID 11895936 DOI: 10.1128/Iai.70.4.1750-1760.2002 |
0.474 |
|
| 2002 |
Zou W, Borvak J, Wei S, Isaeva T, Curiel DT, Curiel TJ. Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection. European Journal of Immunology. 31: 3833-9. PMID 11745405 DOI: 10.1002/1521-4141(200112)31:12<3833::Aid-Immu3833>3.0.Co;2-Y |
0.401 |
|
| 2001 |
Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nature Medicine. 7: 1339-46. PMID 11726975 DOI: 10.1038/Nm1201-1339 |
0.505 |
|
| 2000 |
Balian A, Zou W, Naveau S, Durand-Gasseli I, Bouchet-Delbos L, Foussat A, Galanaud P, Chaput JC, Emilie D. Does pretreatment expression of the perforin gene by circulating CD8+ T lymphocytes predicts biochemical response to interferon alpha in patients with chronic hepatitis C? Gastroenterology. 118: A940. DOI: 10.1016/S0016-5085(00)85900-4 |
0.319 |
|
| 1995 |
Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. The Journal of Experimental Medicine. 181: 839-44. PMID 7869046 DOI: 10.1084/Jem.181.3.839 |
0.363 |
|
| Show low-probability matches. |